US FDA accepts BASF Pharma Solutions excipient, Soluplus into its Pilot Programme

BASF Pharma Solutions announces that the US Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Office of New Drugs, has accepted their excipient, Soluplus, into the FDA